Bharat Immunological & Biological Corporation Share Price Live
BIBCL
Live Bharat Immunological & Biological Corporation Share Price Chart
Bharat Immunological & Biological Corporation Performance
Days Range
| Previous Close | ₹16.26 |
|---|---|
| Open | ₹16.01 |
| Volume | 16,056 |
| Day's Range | ₹15.86 - ₹16.34 |
|---|---|
| 52W Range | ₹14.10 - ₹23.19 |
| Market Cap | ₹70.21 Cr |
Bharat Immunological & Biological Corporation Fundamentals
| ROCE(TTM) | -11.16 |
|---|---|
| P/E Ratio (TTM) | -3.89 |
| P/B Ratio | N/A |
| Industry P/E | 51.11 |
| Debt to Equity | 0.94 |
| ROE | -22.95 |
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | -7.54 |
| Face Value | 10 |
| ROCE(TTM) | -11.16 |
|---|---|
| P/E Ratio (TTM) | -3.89 |
| P/B Ratio | N/A |
| Industry P/E | 51.11 |
| Debt to Equity | 0.94 |
| ROE | -22.95 |
|---|---|
| EPS (TTM) | N/A |
| Dividend Yield | N/A |
| Book Value | -7.54 |
| Face Value | 10 |
Bharat Immunological & Biological Corporation Financials
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | |
|---|---|---|---|---|
| Net Sales | 0.00 | 7.65 | 0.00 | 0.00 |
| Expenses | 4.76 | 11.76 | 4.35 | 4.72 |
| Profit before tax | -6.33 | -5.68 | -5.97 | -6.65 |
| Operating Profit | -4.68 | -3.88 | -4.59 | -4.92 |
| Net Profit | -4.68 | -3.88 | -4.59 | -4.92 |
| EPS in Rs | -1.08 | -0.90 | -1.06 | -1.14 |
Bharat Immunological & Biological Corporation Shareholding Pattern
Promoters
59.25%
Retail And Others
40.75%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.00%
About Bharat Immunological & Biological Corporation
Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations.
The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96.
The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US.
The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.
Parent Organisation
Govt of India
Managing Director
Sanjay Kumar Mishra
Founded
1989
NSE Symbol
Top Mutual Funds Invested in Bharat Immunologicals Biologicals Corporation Share
Data is not available currently. Please check back later.
Peer Comparison
| Stocks | LTP (₹) | Market Cap (cr) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 1,949.6 9.60 (0.49%) | ₹4,67,630.39 | 1,548.0 - 2,046.9 |
| Divis Laboratories Ltd | 8,282.5 -105.50 (-1.26%) | ₹2,21,666.26 | 5,636.5 - 8,585.0 |
| Torrent Pharmaceuticals Ltd | 4,967.5 -32.50 (-0.65%) | ₹1,90,107.85 | 3,480.6 - 5,250.0 |
| Cipla Ltd | 1,474.0 15.20 (1.04%) | ₹1,17,137.57 | 1,165.7 - 1,673.0 |
| Zydus Lifesciences Ltd | 1,103.5 -17.60 (-1.57%) | ₹1,10,822.68 | 835.5 - 1,181.5 |
| Lupin Ltd | 2,388.1 0.10 (0.00%) | ₹1,09,095.68 | 1,836.8 - 2,529.5 |
Popular Stocks
Bharat Immunologicals Biologicals Corporation Ltd FAQs
What is the share price of Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares?
Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) share price as of August 6, 2026, on NSE is Rs 15.92 (NSE) and Rs 15.92 (BSE) on BSE.
Can I buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) from Angel One?
Yes, You can buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares by opening a Demat account with Angel One.
How do I buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) from Angel One?
Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) share can be bought through the following modes:
1. Direct investment: You can buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares.
1. Direct investment: You can buy Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Bharat Immunologicals Biologicals Corporation Ltd (Bharat Immunologicals Biologicals Corporation Ltd) shares.
What is the market cap of Bharat Immunological & Biological Corporation?
The market cap of Bharat Immunological & Biological Corporation is Rs. 70.21 Cr. as of 06/08/2026.
